Maximillian Salcher-Konrad is a Research Officer within CPEC at LSE using structured reviews and meta-analyses to assess current evidence on what works in dementia care in developing countries. He also works as a Research Officer part-time within LSE Health. Maximilian’s research interests include real world evidence, evidence synthesis, study design, decision-making at the patient and population levels and economic evaluation. Maximilian’s PhD research focuses on evidence requirements for drug marketing authorisation. His empirical work includes an evaluation of evidence standards in accelerated access pathways, focusing on the role of non-randomised studies and surrogate measures. He obtained his MSc in Health Policy, Planning and Financing from LSE and LSHTM in 2014. Prior to moving to London, he completed his undergraduate studies in economics at the Vienna University of Economics and Business and worked as a research assistant at the Institute for Advanced Studies in Vienna, Austria.